Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
基本信息
- 批准号:10398922
- 负责人:
- 金额:$ 68.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcquired Immunodeficiency SyndromeAstrocytesAutologousAutopsyBiological ModelsBrainCCL2 geneCXCL10 geneCardiovascular DiseasesCell CommunicationCell Culture TechniquesCell LineCell NucleusCellsCellular Metabolic ProcessChronicClustered Regularly Interspaced Short Palindromic RepeatsDevelopmentExposure toFunctional disorderFutureGenetic TranscriptionHIVHIV InfectionsHIV antiretroviralHIV-1HIV-associated neurocognitive disorderHumanImmuneImmune System DiseasesIncidenceIndividualInfectionInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInterferonsInterruptionInterventionIntronsKnock-outLeadLinkMalignant NeoplasmsMicrogliaMolecularMorphineMyeloid CellsNerve DegenerationNeurocognitiveNeurogliaNeurologic DysfunctionsNeuronal InjuryNeuronsNeuropathogenesisNuclear ExportOpiate AddictionOpioidOrganoidsOsteoporosisPathway interactionsPatientsPeripheral Blood Mononuclear CellPersonsPharmaceutical PreparationsPopulationPredispositionProductionPublishingRNARiskSignal TransductionSurveysTestingTissuesToxic effectViralViral ProteinsViremiaVirusVirus Diseasesantiretroviral therapybasecell injurycell typechronic inflammatory diseasecomorbiditycytokineexperienceimmune activationin vitro Modelin vivoinduced pluripotent stem cellinflammatory markerinjection drug useinnate immune sensingmacrophagemitochondrial dysfunctionmonocytemu opioid receptorsneuroinflammationneurotoxicityopioid abuseopioid exposureopioid injectionopioid useopioid use disorderoverdose deathpathogenperipheral bloodpreventresponsesingle-cell RNA sequencingsocioeconomicssubstance usetherapeutic developmenttranscriptomicsviral DNA
项目摘要
ABSTRACT
Persistent immune activation is the defining feature of HIV-1 infection in vivo and a driver of progression to end-
stage AIDS. Systemic immune activation in people living with HIV has been hypothesized to account for higher
incidence of chronic inflammatory diseases, including HIV-associated neurocognitive disorders (HAND).
Importantly, numerous studies have demonstrated that populations living with opioid-use disorder (OUD) have
a higher occurrence of comorbid HIV infection, suggesting both potential socio-economic and neurocognitive
influence. This comorbidity of OUD and HIV has also been shown to increase neuroinflammation and exacerbate
the progression of HIV infection and HAND. While some studies have investigated the interactive effects of OUD
and HAND in few cell types in isolation, the molecular mechanisms linking the two conditions is still largely
unknown, especially in primary human microglia, neurons and astrocytes. Hence, we believe that this proposal
fulfills a critical unmet need by establishing primary human neuronal cell cultures and an unbiased, systematic
single cell transcriptomic survey of these cultures in the context of co-exposure of opiates and HIV-1 infection.
In this proposal, we will establish 3D spheroid cultures consisting of induced pluripotent stem cell (iPSC)-derived
human microglia, astrocytes and neurons, derived from 10 independent donor lines established at BUMC, that
will recapitulate spatial complexity of cell-to-cell interactions in the brain, and interrogate the effect of HIV
infection and morphine exposure on persistent innate immune activation. We will utilize cutting-edge single cell
transcriptomics analysis to identify the microglia-intrinsic pathway that promotes induction of pro-inflammatory
responses upon co-exposure to HIV and opiates and the neurodegenerative pathways contributing to neuronal
cell injury. Finally, information from these transcriptomic studies will be leveraged to inform CRISPR/Cas-based
knock-out strategies to selectively delete key pathways in iPSC-microglia to alleviate neuroinflammation. We
believe that results from these studies will inform future therapeutic development to prevent HIV and opiate-
induced neuroinflammation and prevent development of HAND in HIV+ substance use population.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine Cheng其他文献
Christine Cheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine Cheng', 18)}}的其他基金
Single Cell Transciptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
- 批准号:
10699022 - 财政年份:2022
- 资助金额:
$ 68.96万 - 项目类别:
Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV
HIV 背景下可卡因使用障碍的单细胞转录组学
- 批准号:
10644020 - 财政年份:2022
- 资助金额:
$ 68.96万 - 项目类别:
Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV
HIV 背景下可卡因使用障碍的单细胞转录组学
- 批准号:
10454684 - 财政年份:2022
- 资助金额:
$ 68.96万 - 项目类别:
Single Cell Transciptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
- 批准号:
10670632 - 财政年份:2022
- 资助金额:
$ 68.96万 - 项目类别:
Exploring the Pathophysiology of AD and ADRDs with 3D Asteroid Models
使用 3D 小行星模型探索 AD 和 ADRD 的病理生理学
- 批准号:
10459727 - 财政年份:2021
- 资助金额:
$ 68.96万 - 项目类别:
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
- 批准号:
10206088 - 财政年份:2020
- 资助金额:
$ 68.96万 - 项目类别:
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
- 批准号:
10613922 - 财政年份:2020
- 资助金额:
$ 68.96万 - 项目类别:
Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection
阿片类药物和 HIV 感染对小胶质细胞慢性先天免疫激活的协同机制
- 批准号:
10055219 - 财政年份:2020
- 资助金额:
$ 68.96万 - 项目类别:
Single Cell Transcriptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
- 批准号:
10296588 - 财政年份:2020
- 资助金额:
$ 68.96万 - 项目类别:
Single Cell Transcriptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
人脑中阿片类药物使用障碍和艾滋病毒综合症的单细胞转录组学
- 批准号:
10241384 - 财政年份:2020
- 资助金额:
$ 68.96万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 68.96万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 68.96万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 68.96万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 68.96万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 68.96万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 68.96万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 68.96万 - 项目类别: